Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

ATOS

Atossa Therapeutics, Inc.

Healthcare · USD

Set alert

Price alert · ATOS

All alert types
2.17 USD -0.06 -2.69%
As of Oct 30, 2026 Extended hours 2.28 +5.04%
Bid
2.17 × 2
Ask
2.18 × 3
2.15 Day range 2.43
1.75 52-week range 13.50
YTD
-75.48%
1 year
-83.56%
Open
2.25
Prev close
2.23
Mkt cap
21.66M
Vol
32.90K
Avg vol
71.57K
EPS
-4.45
P/E
0.00
Div yield
0.00%
More statistics
Low
2.15
High
2.43
Forward P/E
-3.81
Beta
1.23
Short ratio
14.73
Inst. own
28.16%
Dividend
0.00
Ex-div date
50-d avg
1.31
200-d avg
1.39
1y target
6.00

5D chart

Chart tools
Interval
1m5m15m30m
ATOS five-day price chart2.152.272.392.512.63Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

-12.00 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 5

Valuation

P/E -2.2×
FY 2016: -0.7×FY 2017: -0.3×FY 2018: -0.2×FY 2019: -0.8×FY 2020: -0.5×FY 2021: -8.9×FY 2022: -2.5×FY 2023: -3.7×FY 2024: -4.7×FY 2025: -2.2×
FY 2016 5y median -3.7× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 1.9×
FY 2016: 1.3×FY 2017: 0.4×FY 2018: 0.5×FY 2019: 1.0×FY 2020: 0.4×FY 2021: 1.4×FY 2022: 0.6×FY 2023: 1.2×FY 2024: 1.7×FY 2025: 1.9×
FY 2016 5y median 1.4× FY 2025
P/FCF -2.6×
FY 2016: -0.8×FY 2017: -0.5×FY 2018: -0.5×FY 2019: -1.5×FY 2020: -0.9×FY 2021: -11.4×FY 2022: -3.2×FY 2023: -5.3×FY 2024: -5.6×FY 2025: -2.6×
FY 2016 5y median -5.3× FY 2025
EV/EBITDA -1.0×
FY 2016: -0.2×FY 2017: 0.5×FY 2018: 0.5×FY 2019: -0.0×FY 2020: 2.0×FY 2021: -2.5×FY 2022: 1.6×FY 2023: -0.7×FY 2024: -1.9×FY 2025: -1.0×
FY 2016 5y median -1.0× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -39.1%
FY 2016: -129.6%FY 2017: -216.8%FY 2018: -213.9%FY 2019: -68.5%FY 2020: -107.8%FY 2021: -8.8%FY 2022: -31.0%FY 2023: -18.9%FY 2024: -17.7%FY 2025: -39.1%
FY 2016 5y median -18.9% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -88.4%
FY 2016: -205.6%FY 2017: -117.1%FY 2018: -129.5%FY 2019: -131.0%FY 2020: -65.6%FY 2021: -14.9%FY 2022: -22.9%FY 2023: -33.1%FY 2024: -35.7%FY 2025: -88.4%
FY 2016 5y median -33.1% FY 2025
ROIC -94.4%
FY 2016: -234.1%FY 2017: -103.6%FY 2018: -129.5%FY 2019: -130.6%FY 2020: -53.7%FY 2021: -14.9%FY 2022: -23.5%FY 2023: -34.5%FY 2024: -38.6%FY 2025: -94.4%
FY 2016 5y median -34.5% FY 2025
ROA -73.0%
FY 2016: -153.7%FY 2017: -99.5%FY 2018: -97.3%FY 2019: -118.9%FY 2020: -41.6%FY 2021: -14.6%FY 2022: -21.8%FY 2023: -31.3%FY 2024: -33.4%FY 2025: -73.0%
FY 2016 5y median -31.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: -100.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -34.5%
FY 2016: 43.2%FY 2017: 0.9%FY 2018: -59.1%FY 2019: -51.0%FY 2020: 15.4%FY 2021: -40.5%FY 2022: -34.9%FY 2023: -13.3%FY 2024: 12.0%FY 2025: -34.5%
FY 2016 FY 2025
EPS (diluted) -34.7%
FY 2016: 72.9%FY 2017: 57.7%FY 2018: 49.9%FY 2019: 63.1%FY 2020: 3.0%FY 2021: 90.9%FY 2022: -16.7%FY 2023: -14.3%FY 2024: 16.7%FY 2025: -34.7%
FY 2016 FY 2025
Free Cash Flow -41.5%
FY 2016: 61.8%FY 2017: -22.5%FY 2018: -37.6%FY 2019: -0.7%FY 2020: -26.7%FY 2021: -42.3%FY 2022: -26.1%FY 2023: -0.8%FY 2024: -0.4%FY 2025: -41.5%
FY 2016 FY 2025

Financial Health

Current Ratio 5.5×
FY 2016: 3.1×FY 2017: 6.4×FY 2018: 4.0×FY 2019: 10.8×FY 2020: 2.7×FY 2021: 45.2×FY 2022: 21.2×FY 2023: 17.6×FY 2024: 15.0×FY 2025: 5.5×
FY 2016 5y median 17.6× FY 2025
Quick Ratio 5.5×
FY 2016: 3.1×FY 2017: 6.4×FY 2018: 4.0×FY 2019: 10.8×FY 2020: 2.7×FY 2021: 45.2×FY 2022: 20.3×FY 2023: 17.3×FY 2024: 15.0×FY 2025: 5.5×
FY 2016 5y median 17.3× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 1.2×
FY 2016: 0.5×FY 2017: 0.9×FY 2018: 0.9×FY 2019: 0.7×FY 2020: 2.7×FY 2021: 6.6×FY 2022: 4.1×FY 2023: 2.9×FY 2024: 2.8×FY 2025: 1.2×
FY 2016 5y median 2.9× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: -37.3×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31